KISTI Secures Funding for National Quantum Center of Excellence; Names IonQ as Primary Quantum Partner
IonQ’s next-generation quantum system to support new research and cloud infrastructure in South Korea COLLEGE PARK, Md.–(BUSINESS WIRE)–IonQ (NYSE:... Read more.
The Oasis Group Releases Research Report Analyzing Wealth Platforms
Latest Peaks Research study provides financial advisors with empirical analysis of wealth management technology FORT MILL, S.C.–(BUSINESS WIRE)–#AI—The... Read more.
R-LABS Announces $3.5M Investment to Expand its Solutions to Address Canada’s Real Estate and Housing Challenges
Investment included participation by global professional services firm, Hatch, and existing investors across Canada including Oxford Properties, Dorsay Development... Read more.
Peak Claims Group Launches Internal AI-Powered Flood Support App to Enhance Adjuster Accuracy and Compliance
MOBILE, Ala.–(BUSINESS WIRE)–Peak Claims Group, Inc., has officially implemented its Flood Support App across internal teams, including Field Adjusters,... Read more.
Ripple Selects BNY to Custody Ripple USD Reserves
Demonstrates Shared Commitment to building Financial Infrastructure for the Future SAN FRANCISCO–(BUSINESS WIRE)–Today Ripple, the leading provider of... Read more.
New NY3 Facility Positions Options at the Heart of US Trading Infrastructure Expansion
NEW YORK & LONDON & CHICAGO & HONG KONG–(BUSINESS WIRE)–Options Technology (Options), the leading provider of capital markets infrastructure,... Read more.
KredosAi Launches RCS in Production to Hyper-personalize Customer Communications for UScellular, Delivering a New Standard in Customer Experience
BELLEVUE, Wash.–(BUSINESS WIRE)–KredosAi, the leader in human-centric, AI-powered customer engagement, today announced the launch of Rich Communication... Read more.
LEO Pharma Announces Positive 16-Week Interim Results for ADHAND Trial for Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis on the Hands who are Candidates for Systemic Therapy
ADHAND is a phase 3b placebo-controlled clinical trial evaluating the efficacy and safety of tralokinumab in adult patients living with moderate-to-severe atopic... Read more.
TELUS Digital advances special committee process in connection with TELUS Corporation’s non-binding proposal
VANCOUVER, British Columbia–(BUSINESS WIRE)–TELUS Digital Experience (TELUS Digital or the Company) (NYSE and TSX: TIXT), a leading global technology... Read more.
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases Merck... Read more.